Silvant Capital Management’s Insmed INSM Stock Holding History

Silvant Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.11M	Sell	19,761 -144	-0.7%	-$17.4K	0.06%	148
2026 Q1	$3.25M	Buy	19,905 +321	+2%	+$49.4K	0.11%	105
2025 Q4	$3.41M	Buy	+19,584	New	+$3.57M	0.12%	104
2022 Q4	–	Sell	-7,341	Closed	-$158K	–	321
2022 Q3	$158K	Hold	7,341	–	–	0.01%	215
2022 Q2	$145K	Hold	7,341	–	–	0.04%	176
2022 Q1	$173K	Hold	7,341	–	–	0.03%	178
2021 Q4	$200K	Sell	7,341 -472	-6%	-$13.5K	0.03%	176
2021 Q3	$215K	Hold	7,813	–	–	0.04%	178
2021 Q2	$222K	Hold	7,813	–	–	0.04%	177
2021 Q1	$266K	Hold	7,813	–	–	0.05%	168
2020 Q4	$260K	Hold	7,813	–	–	0.04%	169
2020 Q3	$251K	Hold	7,813	–	–	0.05%	159
2020 Q2	$215K	Buy	7,813 +2,543	+48%	+$60.3K	0.04%	164
2020 Q1	$84K	Hold	5,270	–	–	0.02%	210
2019 Q4	$126K	Hold	5,270	–	–	0.02%	212
2019 Q3	$93K	Hold	5,270	–	–	0.02%	227
2019 Q2	$135K	Buy	+5,270	New	+$147K	0.02%	211

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Silvant Capital Management's INSM Position: Q2 2026 in Review

Silvant Capital Management reduced its Insmed (INSM) stake by 0.72% in Q2 2026, selling an estimated $17.4K and leaving 19,761 shares worth $2.11M. The position accounts for 0.06% of the portfolio, ranked #148.

Silvant Capital Management first reported a position in INSM in Q2 2019 and has held it in 17 quarters since. The position peaked at $3.41M in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Silvant Capital Management held 19,761 shares of Insmed worth $2.11M as of Q2 2026.
Silvant Capital Management sold 144 Insmed shares in Q2 2026, an estimated $17.4K.
Insmed made up 0.06% of Silvant Capital Management's portfolio in Q2 2026, its #148 holding.
Silvant Capital Management first reported a position in Insmed in Q2 2019 and has held it in 17 quarters since.
Silvant Capital Management's Insmed position peaked at $3.41M in Q4 2025.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Silvant Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.